Clinical data | |
---|---|
Trade names | Kenalog, Nasacort, Adcortyl, others |
Other names | Click show to see
(8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one; (1R,2S,10S,11S,13R,14S,15S,17S)-1-fluoro-13,14,17-trihydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.02,7.011,15]heptadeca-3,6-dien-5-one |
AHFS/Drugs.com | Monograph |
MedlinePlus | a601122 |
License data | |
Pregnancy category |
|
Routes of administration | By mouth, topical, intranasal, intramuscular, intra-articular, intra-synovial |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | >90%[4] |
Protein binding | 68%[citation needed] |
Metabolism | Liver[4] |
Onset of action | (2–)24(–48) hours[4][5] |
Elimination half-life | 200–300 minutes (plasma), up to 36 hours (total)[4] |
Excretion | Urine (75%) and faeces (25%)[5] |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.004.290 |
Chemical and physical data | |
Formula | C21H27FO6 |
Molar mass | 394.439 g·mol−1 |
3D model (JSmol) | |
Specific rotation | +65° to +72° |
Melting point | 260 to 271 °C (500 to 520 °F) |
Solubility in water | 2 |
| |
| |
(what is this?) (verify) |
Triamcinolone is a glucocorticoid used to treat certain skin diseases, allergies, and rheumatic disorders among others.[6] It is also used to prevent worsening of asthma and chronic obstructive pulmonary disease (COPD).[6] It can be taken in various ways including by mouth, injection into a muscle, and inhalation.[6]
Common side effects with long-term use include osteoporosis, cataracts, thrush, and muscle weakness.[6] Serious side effects may include psychosis, increased risk of infections, adrenal suppression, and bronchospasm.[6] Use in pregnancy is generally safe.[7] It works by decreasing inflammation and immune system activity.[6]
Triamcinolone was patented in 1956 and came into medical use in 1958.[8] It is available as a generic medication.[9] In 2022, it was the 102nd most commonly prescribed medication in the United States, with more than 6 million prescriptions.[10][11]
PPA
was invoked but never defined (see the help page).